Literature DB >> 31931470

REM sleep behavior disorder in narcolepsy: A secondary form or an intrinsic feature?

Elena Antelmi1, Fabio Pizza1, Christian Franceschini2, Raffaele Ferri3, Giuseppe Plazzi4.   

Abstract

Disrupted nighttime sleep is one of the pentad of symptoms defining Narcolepsy. REM sleep behavior disorder (RBD) largely contributes to night sleep disruption and narcolepsy is the most common cause of secondary RBD. However, RBD linked to narcolepsy (N-RBD) has been insufficiently characterized, leaving unsolved a number of issues. Indeed, it is still debated whether N-RBD is an intrinsic feature of narcolepsy, as indubitable for cataplexy, and therefore strictly linked to the cerebrospinal fluid hypocretin-1 (CSF hcrt-1) deficiency, or an associated feature, with a still unclear pathophysiology. The current review aims at rendering a comprehensive state-of-the-art of N-RBD, highlighting the open and unsettled topics. RBD reportedly affects 30-60% of patients with Narcolepsy type 1 (NT1), but it may be seen also in Narcolepsy type 2 (NT2). When compared to idiopathic/isolated RBD (iRBD), N-RBD has been reported to be characterized by less energetic and quieter episode, which however occur with the same probability in the first and the second part of the night and sometime even subcontinuously. N-RBD patients are generally younger than those with iRBD. N-RBD has been putatively linked to wake-sleep instability due to CSF hcrt-1 deficiency, but this latter by itself cannot explain completely the phenomenon as N-RBD has not been universally linked to low CSF hcrt-1 levels and it may be observed also in NT2. Therefore, other factors may probably play a role and further studies are needed to clarify this issue. In addition, therapeutic options have been poorly investigated.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disrupted sleep; Isolated RBD; Narcolepsy; REM sleep behaviour disorder; Secondary RBD

Mesh:

Substances:

Year:  2019        PMID: 31931470     DOI: 10.1016/j.smrv.2019.101254

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  7 in total

Review 1.  Clonazepam for the management of sleep disorders.

Authors:  Alberto Raggi; Maria Paola Mogavero; Lourdes M DelRosso; Raffaele Ferri
Journal:  Neurol Sci       Date:  2022-09-16       Impact factor: 3.830

Review 2.  REM sleep behavior disorder as a complex condition with heterogeneous underlying disorders: clinical management and prognostic implications [Commentary].

Authors:  Carlos H Schenck
Journal:  Sleep Breath       Date:  2022-03-03       Impact factor: 2.655

3.  Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: more REM than NREM parasomnias.

Authors:  Smaranda Leu-Semenescu; Jean-Baptiste Maranci; Régis Lopez; Xavier Drouot; Pauline Dodet; Ana Gales; Elisabeth Groos; Lucie Barateau; Patricia Franco; Michel Lecendreux; Yves Dauvilliers; Isabelle Arnulf
Journal:  J Clin Sleep Med       Date:  2022-05-01       Impact factor: 4.324

Review 4.  Narcolepsy Presentation in Diverse Populations: an Update.

Authors:  Karen Spruyt
Journal:  Curr Sleep Med Rep       Date:  2020-11-25

Review 5.  Neuropathology and molecular diagnosis of Synucleinopathies.

Authors:  Shunsuke Koga; Hiroaki Sekiya; Naveen Kondru; Owen A Ross; Dennis W Dickson
Journal:  Mol Neurodegener       Date:  2021-12-18       Impact factor: 14.195

Review 6.  Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review.

Authors:  Michela Figorilli; Giuseppe Lanza; Patrizia Congiu; Rosamaria Lecca; Elisa Casaglia; Maria P Mogavero; Monica Puligheddu; Raffaele Ferri
Journal:  Brain Sci       Date:  2021-11-30

7.  REM Sleep Behavior Disorder in Children With Type 1 Narcolepsy Treated With Sodium Oxybate.

Authors:  Elena Antelmi; Marco Filardi; Fabio Pizza; Stefano Vandi; Monica Moresco; Christian Franceschini; Michele Tinazzi; Raffaele Ferri; Giuseppe Plazzi
Journal:  Neurology       Date:  2020-11-11       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.